20811-60-3

Basic information

• Product Name: 3-(4-METHOXYPHENOXY)PROPANOIC ACID
• Synonyms: BUTTPARK 80\07-08;IFLAB-BB F1575-0111;AKOS BC-0464;3-(4-METHOXYPHENOXY)PROPANOIC ACID;3-(4-METHOXY-PHENOXY)-PROPIONIC ACID;3-(p-Methoxyphenoxy)propanoic acid;3-(p-Methoxyphenoxy)propionic acid;Propanoic acid,3-(4-Methoxyphenoxy)-
• CAS NO: 20811-60-3
• Molecular Formula: C₁₀H₁₂O₄
• Molecular Weight: 196.2
• Mol File: 20811-60-3.mol
• Article Data: 18

Chemical Properties

• Melting Point: 110.5 °C
• Boiling Point: 321.7 °C at 760 mmHg
• Flash Point: 125.6 °C
• Appearance: /
• Density: 1.188 g/cm³
• Vapor Pressure: 0.000121mmHg at 25°C
• Refractive Index: 1.523
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 4.14±0.10(Predicted)
• CAS DataBase Reference: 3-(4-METHOXYPHENOXY)PROPANOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-METHOXYPHENOXY)PROPANOIC ACID(20811-60-3)
• EPA Substance Registry System: 3-(4-METHOXYPHENOXY)PROPANOIC ACID(20811-60-3)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 20811-60-3(Hazardous Substances Data)

Usage

General Description

3-(4-Methoxyphenoxy)propanoic acid is a chemical compound with the formula C10H12O4. It is also known as MPYA and is commonly used as a synthetic intermediate in the production of pharmaceuticals and agrochemicals. 3-(4-METHOXYPHENOXY)PROPANOIC ACID is a white to off-white crystalline powder with a molecular weight of 196.2 g/mol. It is a carboxylic acid derivative with a phenolic group and a propionic acid group, making it a versatile building block for the synthesis of various organic compounds. MPYA has applications in the manufacturing of anti-inflammatory drugs, herbicides, and fungicides, making it a valuable chemical in the pharmaceutical and agricultural industries.

InChI:InChI=1/C10H12O4/c1-13-8-2-4-9(5-3-8)14-7-6-10(11)12/h2-5H,6-7H2,1H3,(H,11,12)

Upstream product

• 1122-95-8 sodium 4-methoxyphenolate 
• 150-76-5 4-methoxy-phenol 
• 590-92-1 3-Bromopropionic acid 
• 107-94-8 chloropropionic acid 
• 82872-99-9 ethyl 3-(p-methoxyphenoxy)propionate 
• 63815-39-4 2-(4-Methoxyphenoxy)cyanoethane 
• 57-57-8 β-Propiolactone 

Downstream Products

• 1092467-10-1 N-[2-hydroxy-2-(2,3-dihydrobenzo[β][1,4]dioxin-6-yl)-1-pyrrolidin-1-ylmethyl-ethyl]-3-(4-methoxy-phenoxy)-propionamide L-tartrate 
• 956895-37-7 N-[2-hydroxy-2-(2,3-dihydrobenzo[β][1,4]dioxin-6-yl)-1-pyrrolidin-1-ylmethyl-ethyl]-3-(4-methoxy-phenoxy)-propionamide 
• 1092468-09-1 N-((1R,2R)-1-(2,3-dihydrobenzo[β][1,4]dioxin-6-yl)-1-hydroxy-3-morpholinopropan-2-yl)-3-(4-methoxyphenoxy)propanamide 
• 1092468-13-7 N-((1R,2R)-1-(2,3-dihydrobenzo[β][1,4]dioxin-6-yl)-1-hydroxy-3-(piperidin-1-yl)propan-2-yl)-3-(4-methoxyphenoxy)propanamide 
• 1284217-58-8 3-[2,5-bis(bromomethyl)-4-methoxyphenoxy]propanoic acid 
• 885604-53-5 (E)-3-[(4-hydroxyphenyl)methylene]-6-methoxy-chroman-4-one 
• 20920-98-3 6-methoxy-3,4-dihydrocoumarin 
• 58228-82-3 3-(4-Methoxy-phenoxy)-thiopropionic acid S-tert-butyl ester 
• 39223-40-0 3-(4-hydroxy-phenoxy)-propionic acid 
• 5802-17-5 6-methoxychroman-4-one 

Relevant articles and documents

Design, synthesis and preliminary bioactivity evaluation of bitopic benzopyranomorpholine analogues as selective dopamine D3 receptor ligands as anti-drug addiction therapeutic agents

Three series of bitopic benzopyranomorpholine analogues were designed, synthesized, and evaluated as a novel class of selective ligands for the dopamine D3 receptor. Binding affinities of target compounds were determined using the method of radioligand binding assay. Most compounds demonstrated considerable binding affinities and selectivity for D3 receptor. Besides, the compounds were screened for their ability to alleviate withdrawal symptoms of opioid addiction in animal behavioral models. The results showed that compound 20h displayed nanomolar affinity for the D3R, and exhibited anti-drug addiction efficacy in the animal model of of naloxone-induced withdrawal symptoms in morphine-dependent mice.

Hydrated ferric sulfate-catalyzed reactions of indole with aldehydes, ketones, cyclic ketones, and chromanones: Synthesis of bisindoles and trisindoles

Hydrated ferric sulfate [Fe2(SO4)3·xH2O] has been found to be an efficient catalyst for condensation of bisindoles or trisindoles with aliphatic or aryl aldehydes and ketones including methyl and ethyl-alkyl ketones, methyl aryl ketones, cyclic ketones, and 4-chromanones in 19–96% yields. Trisindoles and 2,2'-alkylidenebisindoles were obtained from indole-3-carbaldehydes or 3-methylindole in 72–84% yields. A total of 43 substrates was employed, giving 33 bisindoles, 3 trisindoles, and one 2:2 product; seventeen of these are new. The best results were obtained from heating ethanolic suspensions, with Fe2(SO4)3·xH2O loaded at 60 mg per mmol of electrophiles. The reaction times were typically 1–4 h, while hindered electrophiles required 8–24 h. These conditions were strong enough to promote 2:1 condensation of indole with substrates without forming higher-order byproducts, with few exceptions. This strategy features tolerance by the catalyst of a wide range of functional groups, readily available starting materials, simple operation, mild reaction conditions, and is environmentally friendly.

METHOD OF TREATING POLYCYSTIC KIDNEY DISEASES WITH CERAMIDE DERIVATIVES

PROBLEM TO BE SOLVED: To provide a method of treating polycystic kidney diseases with ceramide derivatives. SOLUTION: A pharmaceutical composition for treating polycystic kidney disease in a subject comprises an effective amount of a predetermined compoun